Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ALI HEALTH
00241
5
TENCENT
00700
US Stock MarketDetailed Quotes
Adial Pharmaceuticals (ADIL)
- 0.3251
- +0.0061+1.91%
Close Nov 14 16:00 ET
- 0.3155
- -0.0096-2.95%
Post 20:01 ET
7.80MMarket Cap-0.54P/E (TTM)
0.3300High0.3100Low358.52KVolume0.3130Open0.3190Prev Close114.54KTurnover1.50%Turnover RatioLossP/E (Static)23.99MShares1.300052wk High1.73P/B7.76MFloat Cap0.220052wk Low--Dividend TTM23.88MShs Float236.0000Historical High--Div Yield TTM6.27%Range %0.2200Historical Low0.3190Avg Price1Lot Size
Adial Pharmaceuticals (ADIL) Analyst Ratings, Stock Forecast and Price Target
ADIL Price Target for the Next 12 Months
Last Updated: Oct 31, 2025
The average Adial Pharmaceuticals stock price target is 1.50 with a max estimate of 1.50 and a min estimate of 1.50
Unlock Price Targets
Review Adial Pharmaceuticals earnings estimates
Detailed Ratings
Receive timely notifications of rating changes
View more detailed ratings of institutions and analysts
View rating details page for historical data
Download APP
Analyst Ratings Disclaimer
Market Insights
HK Tech and Internet Stocks HK Tech and Internet Stocks
Stocks of companies primarily involved in technology and internet sectors in the HK stock market. Stocks of companies primarily involved in technology and internet sectors in the HK stock market.
View More
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
Hot Topics
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome
牛牛課堂
Oct 13 18:05
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?